A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation

Sakuma Takahashi, Teizo Yoshimura, Takahiro Ohkura, Masayoshi Fujisawa, Soichiro Fushimi, Toshihiro Ito, Junya Itakura, Sakiko Hiraoka, Hiroyuki Okada, Kazuhide Yamamoto, Akihiro Matsukawa

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Rapid and adequate mucosal healing is important for a remission of ulcerative colitis (UC) patients. Here, we examined whether Spred2, a member of the Sprouty-related EVH1-domain-containing proteins that inhibit the Ras/Raf/ERK pathway, plays a role in colonic mucosal homeostasis and inflammation by using Spred2 knockout (KO) mice. We first detected increased epithelial cell proliferation and cadherin 1 expression in the colon of naïve Spred2 KO mice compared to wild-type mice. Interestingly, Spred2 KO mice were resistant to dextran sulfate sodium (DSS)-induced acute colitis as indicated by lower levels of body weight loss and disease activity index. Histologically, epithelial cell injury and inflammation were milder in the colonic mucosa of Spred2 KO mice on day 3 and almost undetectable by day 8. Experiments with bone chimeric mice indicated that Spred2-deficiency in non-hematopoietic cells was responsible for the reduced sensitivity to DSS. Finally, Spred2 KO mice developed significantly fewer tumors in response to azoxymethane plus DSS. Taken together, our results demonstrate, for the first time, that Spred2 plays an important role in the regulation of colonic epithelial cell proliferation and inflammation by potentially down-regulating the activation of ERK. Thus, Spred2 may be a new therapeutic target for the treatment of UC.

Original languageEnglish
Article number37531
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - Nov 21 2016

Fingerprint

Knockout Mice
Homeostasis
Epithelial Cells
Dextran Sulfate
Inflammation
Cadherins
Ulcerative Colitis
Cell Proliferation
Azoxymethane
ras Proteins
MAP Kinase Signaling System
Colitis
Weight Loss
Colon
Mucous Membrane
Body Weight
Bone and Bones
Wounds and Injuries
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • General

Cite this

A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation. / Takahashi, Sakuma; Yoshimura, Teizo; Ohkura, Takahiro; Fujisawa, Masayoshi; Fushimi, Soichiro; Ito, Toshihiro; Itakura, Junya; Hiraoka, Sakiko; Okada, Hiroyuki; Yamamoto, Kazuhide; Matsukawa, Akihiro.

In: Scientific Reports, Vol. 6, 37531, 21.11.2016.

Research output: Contribution to journalArticle

Takahashi, Sakuma ; Yoshimura, Teizo ; Ohkura, Takahiro ; Fujisawa, Masayoshi ; Fushimi, Soichiro ; Ito, Toshihiro ; Itakura, Junya ; Hiraoka, Sakiko ; Okada, Hiroyuki ; Yamamoto, Kazuhide ; Matsukawa, Akihiro. / A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation. In: Scientific Reports. 2016 ; Vol. 6.
@article{8783ce323bc54bb8b81fb4e0cd1818c9,
title = "A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation",
abstract = "Rapid and adequate mucosal healing is important for a remission of ulcerative colitis (UC) patients. Here, we examined whether Spred2, a member of the Sprouty-related EVH1-domain-containing proteins that inhibit the Ras/Raf/ERK pathway, plays a role in colonic mucosal homeostasis and inflammation by using Spred2 knockout (KO) mice. We first detected increased epithelial cell proliferation and cadherin 1 expression in the colon of na{\"i}ve Spred2 KO mice compared to wild-type mice. Interestingly, Spred2 KO mice were resistant to dextran sulfate sodium (DSS)-induced acute colitis as indicated by lower levels of body weight loss and disease activity index. Histologically, epithelial cell injury and inflammation were milder in the colonic mucosa of Spred2 KO mice on day 3 and almost undetectable by day 8. Experiments with bone chimeric mice indicated that Spred2-deficiency in non-hematopoietic cells was responsible for the reduced sensitivity to DSS. Finally, Spred2 KO mice developed significantly fewer tumors in response to azoxymethane plus DSS. Taken together, our results demonstrate, for the first time, that Spred2 plays an important role in the regulation of colonic epithelial cell proliferation and inflammation by potentially down-regulating the activation of ERK. Thus, Spred2 may be a new therapeutic target for the treatment of UC.",
author = "Sakuma Takahashi and Teizo Yoshimura and Takahiro Ohkura and Masayoshi Fujisawa and Soichiro Fushimi and Toshihiro Ito and Junya Itakura and Sakiko Hiraoka and Hiroyuki Okada and Kazuhide Yamamoto and Akihiro Matsukawa",
year = "2016",
month = "11",
day = "21",
doi = "10.1038/srep37531",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - A Novel Role of Spred2 in the Colonic Epithelial Cell Homeostasis and Inflammation

AU - Takahashi, Sakuma

AU - Yoshimura, Teizo

AU - Ohkura, Takahiro

AU - Fujisawa, Masayoshi

AU - Fushimi, Soichiro

AU - Ito, Toshihiro

AU - Itakura, Junya

AU - Hiraoka, Sakiko

AU - Okada, Hiroyuki

AU - Yamamoto, Kazuhide

AU - Matsukawa, Akihiro

PY - 2016/11/21

Y1 - 2016/11/21

N2 - Rapid and adequate mucosal healing is important for a remission of ulcerative colitis (UC) patients. Here, we examined whether Spred2, a member of the Sprouty-related EVH1-domain-containing proteins that inhibit the Ras/Raf/ERK pathway, plays a role in colonic mucosal homeostasis and inflammation by using Spred2 knockout (KO) mice. We first detected increased epithelial cell proliferation and cadherin 1 expression in the colon of naïve Spred2 KO mice compared to wild-type mice. Interestingly, Spred2 KO mice were resistant to dextran sulfate sodium (DSS)-induced acute colitis as indicated by lower levels of body weight loss and disease activity index. Histologically, epithelial cell injury and inflammation were milder in the colonic mucosa of Spred2 KO mice on day 3 and almost undetectable by day 8. Experiments with bone chimeric mice indicated that Spred2-deficiency in non-hematopoietic cells was responsible for the reduced sensitivity to DSS. Finally, Spred2 KO mice developed significantly fewer tumors in response to azoxymethane plus DSS. Taken together, our results demonstrate, for the first time, that Spred2 plays an important role in the regulation of colonic epithelial cell proliferation and inflammation by potentially down-regulating the activation of ERK. Thus, Spred2 may be a new therapeutic target for the treatment of UC.

AB - Rapid and adequate mucosal healing is important for a remission of ulcerative colitis (UC) patients. Here, we examined whether Spred2, a member of the Sprouty-related EVH1-domain-containing proteins that inhibit the Ras/Raf/ERK pathway, plays a role in colonic mucosal homeostasis and inflammation by using Spred2 knockout (KO) mice. We first detected increased epithelial cell proliferation and cadherin 1 expression in the colon of naïve Spred2 KO mice compared to wild-type mice. Interestingly, Spred2 KO mice were resistant to dextran sulfate sodium (DSS)-induced acute colitis as indicated by lower levels of body weight loss and disease activity index. Histologically, epithelial cell injury and inflammation were milder in the colonic mucosa of Spred2 KO mice on day 3 and almost undetectable by day 8. Experiments with bone chimeric mice indicated that Spred2-deficiency in non-hematopoietic cells was responsible for the reduced sensitivity to DSS. Finally, Spred2 KO mice developed significantly fewer tumors in response to azoxymethane plus DSS. Taken together, our results demonstrate, for the first time, that Spred2 plays an important role in the regulation of colonic epithelial cell proliferation and inflammation by potentially down-regulating the activation of ERK. Thus, Spred2 may be a new therapeutic target for the treatment of UC.

UR - http://www.scopus.com/inward/record.url?scp=84995952537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995952537&partnerID=8YFLogxK

U2 - 10.1038/srep37531

DO - 10.1038/srep37531

M3 - Article

C2 - 27869219

AN - SCOPUS:84995952537

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 37531

ER -